BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.990
+0.070 (1.42%)
At close: Mar 26, 2026
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $84.11 million as of March 26, 2026. Its market cap has decreased by -55.94% in one year.
Market Cap
84.11M
Enterprise Value
57.89M
Revenue
47.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.99
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 84.11M, an increase of 1,661.67%. That is a compound annual growth rate of 18.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 82.93M | 29.56% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 245.62M |
| Vaxart | 167.00M |
| HST Global | 88.40M |
| Nuo Therapeutics | 62.78M |
| Vicapsys Life Sciences | 48.56M |
| Anebulo Pharmaceuticals | 42.01M |
| Cell Source | 37.29M |
| ZIVO Bioscience | 33.01M |